Literature DB >> 9631873

Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry.

E H Locati1, W Zareba, A J Moss, P J Schwartz, G M Vincent, M H Lehmann, J A Towbin, S G Priori, C Napolitano, J L Robinson, M Andrews, K Timothy, W J Hall.   

Abstract

BACKGROUND: Unexplained female predominance is observed in long-QT syndrome (LQTS), a congenital autosomal disorder with prolonged repolarization and syncope or sudden death due to ventricular tachyarrhythmias. Our objectives were to evaluate age- and sex-related differences in events among LQTS patients referred to the LQTS International Registry. METHODS AND
RESULTS: Age- and sex-related occurrence of events was analyzed in 479 probands (70% females) and 1041 affected family members (QTc >440 ms, 58% females). LQTS-gene mutations were identified in 162 patients: 69 LQT1 carriers (KVLQT1 on 11p15.5), 62 LQT2 carriers (HERG on 7q35-36), and 31 LQT3 carriers (SCN5A on 3p21-24). Females predominated among 366 probands (71% females) and 230 symptomatic family members (62% females). Male probands were younger than females at first event (8+/-7 versus 14+/-10 years, P<0.0001) and had higher event rates by age 15 years than females (74% versus 51%, P<0.0001). Affected family members had similar findings. By Cox analysis adjusting for QTc duration, the hazard ratio for female probands of experiencing events by age 15 years was 0.48 (P<0.001), and it was 1.87 (P=0.09) by age 15 to 40 years. In female family members, the hazard ratio was 0.58 (P<0.001) by age 15 years, and it was 3.25 (P<0.001) by age 15 to 40 years. The event rate was higher in male than female LQT1 carriers (69% versus 32%, P=0.001). No age-sex difference in event rate was detected in LQT2 and LQT3 carriers.
CONCLUSIONS: Among LQTS patients, the risk of cardiac events was higher in males until puberty and higher in females during adulthood. The same pattern was evident among LQT1 gene carriers. Unknown sex factors modulate QT duration and arrhythmic events, with preliminary evidence of gene-specific differences in age-sex modulation.

Entities:  

Mesh:

Year:  1998        PMID: 9631873     DOI: 10.1161/01.cir.97.22.2237

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  98 in total

1.  Prolongation of the QTc interval in HIV-infected individuals compared to the general population.

Authors:  Nico Reinsch; Marina Arendt; Marie Henrike Geisel; Christina Schulze; Volker Holzendorf; Anna Warnke; Till Neumann; Norbert H Brockmeyer; Dirk Schadendorf; Lewin Eisele; Raimund Erbel; Susanne Moebus; Karl-Heinz Jöckel; Stefan Esser
Journal:  Infection       Date:  2017-08-03       Impact factor: 3.553

2.  Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2.

Authors:  Jonathan Buber; Jehu Mathew; Arthur J Moss; W Jackson Hall; Alon Barsheshet; Scott McNitt; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Elizabeth S Kaufman; David Luria; Michael Eldar; Jeffrey A Towbin; Michael Vincent; Ilan Goldenberg
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

Review 3.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

Review 4.  How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.

Authors:  Katja E Odening; Gideon Koren
Journal:  Heart Rhythm       Date:  2014-06-19       Impact factor: 6.343

Review 5.  [Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].

Authors:  D Duncker; T König; S Hohmann; C Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-05-22

6.  Influence of genetic modifiers on sudden cardiac death cases.

Authors:  Tina Jenewein; Thomas Neumann; Damir Erkapic; Malte Kuniss; Marcel A Verhoff; Gerhard Thiel; Silke Kauferstein
Journal:  Int J Legal Med       Date:  2017-12-06       Impact factor: 2.686

Review 7.  Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias.

Authors:  Robert S Kass; Arthur J Moss
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Authors:  Arthur J Moss; Wataru Shimizu; Arthur A M Wilde; Jeffrey A Towbin; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Michael J Ackerman; Elizabeth S Kaufman; Nynke Hofman; Rahul Seth; Shiro Kamakura; Yoshihiro Miyamoto; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

Review 9.  Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.

Authors:  Ijaz A Khan; Chandra K Nair
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

Review 10.  Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood.

Authors:  Gregory Webster; Charles I Berul
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.